Kenji Mimatsu, Takatsugu Oida, Atsushi Kawasaki, Hisao Kano, Youichi Kuboi, Osamu Aramaki, Department of Surgery, Social Insurance Yokohama Central Hospital, Kanagawa 231-8553, Japan

Sadao Amano, Department of Surgery, Nihon University School of Medicine, Tokyo 173-0032, Japan

Author contributions: Mimatsu K, Oida T, Kawasaki A, Kano H, Kuboi Y and Aramaki O carried out the operation and were consultant overseeing the patient’s care; Mimatsu K wrote the manuscript; Amano S was responsible for drafting the manuscript and revising it critically.

Correspondence to: Kenji Mimatsu, MD, Department of Surgery, Social Insurance Yokohama Central Hospital, 268 Yamashita-cho Naka-ku Yokohama, Kanagawa 231-8553, Japan. mimatsu.kenji@yokochu.jp

Telephone: +81-45-6411921   Fax: +81-45-6719872

Received: February 20, 2008  Revised: April 30, 2008

Accepted: May 6, 2008

Published online: May 28, 2008

Abstract

Pneumatosis cystoides intestinalis (PCI) is a relatively rare condition characterized by intraluminal gas in the gastrointestinal tract. Several chemotherapeutic agents have been reported to be associated with PCI, although fluorouracil-related PCI is extremely rare. We report a case of a 76-year old man who received adjuvant chemotherapy for rectal cancer with fluorouracil (FU) and leucovorin (LV). After 1 cycle of the treatment, he presented with diarrhea and abdominal pain. Abdominal radiogram revealed the presence of free air under the diaphragm and intramural gas in the intestine. Laparotomy was performed, showing a suspected diagnosis of perforation in the gastrointestinal tract. Intraoperative findings revealed pneumatosis of the intestine without evidence of perforation. He was treated supportively and his symptoms improved. In conclusion, we should consider the possibility of PCI occurring in patients with malignancies during chemotherapy treatment.

© 2008 The WJG Press. All rights reserved.

Key words: Pneumatosis cystoides intestinalis; Chemotherapy; Fluorouracil; Colorectal cancer

Peer reviewer: Damian Casadesus Rodriguez, MD, PhD, Calixto Garcia University Hospital, J and University, Vedado, Havana City, Cuba

Mimatsu K, Oida T, Kawasaki A, Kano H, Kuboi Y, Aramaki O, Amano S. Pneumatosis cystoides intestinalis after fluorouracil chemotherapy for rectal cancer. World J Gastroenterol 2008; 14(20): 3273-3275  Available from: URL: http://www.wjgnet.com/1007-9327/14/3273.asp  DOI: http://dx.doi.org/10.3748/wjg.14.3273

INTRODUCTION

Fluorouracil (FU) is one of the most commonly used chemotherapeutic agents in clinical oncology regimens. With regard to colorectal cancer, treatment involving FU with leucovorin (LV) can improve the survival, tumor response and quality of life^[1] of patients. We report a case of pneumatosis cystoides intestinalis (PCI) in a patient who received adjuvant chemotherapy with 5-FU and l-LV^[2]. To our knowledge, FU-related or FU-induced PCI has not been reported previously. This case will add to the reported series of patients with FU-induced small bowel toxicity^[3,4] and chemotherapy-related PCI^[5-9].

CASE REPORT

A 76-year-old male underwent anterior resection for stage Ⅲ rectal cancer. He received an adjuvant chemotherapy protocol comprising intravenous bolus injection of 600 mg/m² 5-FU at 1 h after the initiation of 2 h-long 250 mg/m² l-LV infusion, once a week for 6 wk, followed by 2 wk of rest^[2]. After 1 cycle of this treatment, the patient presented with diarrhea and abdominal pain. Although his abdomen was distended, he did not exhibit any peritoneal signs. He was afebrile and had no neutropenia. His stool culture was negative. An abdominal radiogram revealed the presence of free air under the diaphragm and intramural gas in the entire intestine (Figure 1). Abdominal computed tomography (CT) revealed the presence of free air in the intestinal wall, retroperitoneal space (Figure 2A), and falciform ligament (Figure 2B). Since bowel perforation was strongly suspected, an emergency operation was performed. Laparotomy revealed pneumatosis of the intestine (Figure 3)
and colon, and pneumoretroperitoneum without evidence of perforation. Therefore, gastrostomy was performed to reduce the pressure in the bowel. PCI was disappeared within 2 wk after parenteral nutrition, antibiotic treatment and oxygen therapy. Enema showed no incidence of anastomotic stenosis and he administered oral uracil-ftorafur, and no recurrence of PCI was observed during the 1-year follow-up.

DISCUSSION

PCI is relatively rare condition characterized by multiple intraluminal gases existing in any part of the gastrointestinal tract. The mechanism and etiology of PCI are not fully understood. According to most hypotheses, mechanical and bacterial factors are the predominant causes for PCI^[10-12]. However, in this present case, no mechanical or bacterial factors, including bowel ischemia, bowel obstruction^[13,14], inflammatory bowel disease and infectious colitis, for the gas production in the intestinal wall were observed.

Several chemotherapeutic agents have been reported to be associated with PCI, including cyclophosphamide, cytarabine, vincristine, doxorubicin, daunorubicin, etoposide, docetaxel, irinotecan and cisplatin^[5-9]. Although fluorouracil-related PCI has not been previously described, the cytotoxic effect of chemotherapy on the epithelial bowel can also play a role in the pathogenesis of PCI^[7]. Because the intestinal mucosa is highly proliferative, mucosal damage occurs easily during chemotherapy^[6]. Moreover, the chemotherapeutic agent might interfere with the mucosal integrity of the intestinal tract, resulting in extensive intramural air^[8]. Tamura et al^[15] reported that PCI following chemotherapy might be due to depletion of submucosal lymphoid tissue or leukemic infiltrates, such as denuded Peyer’s patches producing mucosal defects, thereby permitting entry of gas into the bowel wall. It was reported that chemotherapy-related PCI occurs due to immunosuppressive treatment for hematological malignancies^[5,6]. Neutropenia is an important factor for the development of PCI^[5-9]. However, the current patient did not suffer from neutropenia before or when PCI was diagnosed.

Several studies have reported severe erosion and superficial ulceration in the ileum after chemotherapy comprising 5-FU and LV in colon cancer patients^[3,4]. The mechanisms are thought to be multifactorial, including alteration in the local mucosal blood flow and thrombogenic and vasospastic effects of 5-FU on the vascular epithelium^[5]. The mechanism underlying 5-FU-induced PCI is thought to be multifactorial, including bowel toxicity caused by 5-FU itself.

In conclusion, although PCI is a rare complication of chemotherapy, the possibility of PCI occurring in patients undergoing chemotherapy should be kept in mind.

ACKNOWLEDGMENTS

The written consent was obtained from the patient for publication of this case report.

REFERENCES

1         Poon MA, O'Connell MJ, Wieand HS, Krook JE, Gerstner JB, Tschetter LK, Levitt R, Kardinal CG, Mailliard JA.     Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in     advanced colorectal cancer. J Clin Oncol 1991; 9: 1967-1972   PubMed 

2         Yoshino M, Ota K, Kurihara M, Akazawa S, Tominaga T, Sasaki T, Konishi T, Kodaira S, Kumai K, Sugano K. [Late     phase II trial of high-dose l-leucovorin and 5-fluorouracil in advanced colorectal carcinoma. l-Leucovorin and 5-FU     Study Group (Japan Eastern Group)] Gan To Kagaku Ryoho 1995; 22: 785-792   PubMed 

3         Fata F, Ron IG, Kemeny N, O'Reilly E, Klimstra D, Kelsen DP. 5-fluorouracil-induced small bowel toxicity in patients with     colorectal carcinoma. Cancer 1999; 86: 1129-1134   PubMed  DOI

4         Bucaloiu ID, Dubagunta S, Pachipala KK, Kamal N, Fata F. Small-cell cancers, and an unusual reaction to     chemotherapy: Case 4. Fluorouracil-related small bowel vasculitis. J Clin Oncol 2003; 21: 2442-2443   PubMed  DOI

5         Galm O, Fabry U, Adam G, Osieka R. Pneumatosis intestinalis following cytotoxic or immunosuppressive treatment.     Digestion 2001; 64: 128-132   PubMed  DOI

6         Hashimoto S, Saitoh H, Wada K, Kobayashi T, Furushima H, Kawai H, Shinbo T, Funakoshi K, Takahashi H, Shibata A.     Pneumatosis cystoides intestinalis after chemotherapy for hematological malignancies: report of 4 cases. Intern Med     1995; 34: 212-215   PubMed  DOI

7         Candelaria M, Bourlon-Cuellar R, Zubieta JL, Noel-Ettiene LM, Sanchez-Sanchez JM. Gastrointestinal pneumatosis     after docetaxel chemotherapy. J Clin Gastroenterol 2002; 34: 444-445   PubMed  DOI

8         Shih IL, Lu YS, Wang HP, Liu KL. Pneumatosis coli after etoposide chemotherapy for breast cancer. J Clin Oncol 2007;    25: 1623-1625   PubMed  DOI

9         Kung D, Ruan DT, Chan RK, Ericsson ML, Saund MS. Pneumatosis intestinalis and portal venous gas without bowel    ischemia in a patient treated with irinotecan and cisplatin. Dig Dis Sci 2008; 53: 217-219   PubMed  DOI

10      Heng Y, Schuffler MD, Haggitt RC, Rohrmann CA. Pneumatosis intestinalis: a review. Am J Gastroenterol 1995; 90:    1747-1758   PubMed 

11      Shindelman LE, Geller SA, Wisch N, Bauer JJ. Pneumatosis cystoides intestinalis: a complication of systemic    chemotherapy. Am J Gastroenterol 1981; 75: 270-274   PubMed 

12      Rogy MA, Mirza DF, Kovats E, Rauhs R. Pneumatosis cystoides intestinalis (PCI). Int J Colorectal Dis 1990; 5: 120-124     PubMed  DOI

13      Horiuchi A, Akamatsu T, Mukawa K, Ochi Y, Arakura N, Kiyosawa K. Case report: Pneumatosis cystoides intestinalis    associated with post-surgical bowel anastomosis: a report of three cases and review of the Japanese literature. J    Gastroenterol Hepatol 1998; 13: 534-537   PubMed  DOI

14      Knechtle SJ, Davidoff AM, Rice RP. Pneumatosis intestinalis. Surgical management and clinical outcome. Ann Surg    1990; 212: 160-165   PubMed 

15      Tamura N, Kojo H, Miyoshi Y, Fukumoto S, Hirayama C. Pneumatosis cystoides intestinalis: Report of 3 cases with    special reference to its non-surgical treatment. Z Gastroenterol 1980; 18: 617-624   PubMed 

                S- Editor  Li DL    L- Editor  Wang XL    E- Editor  Liu Y

Reviews	Add
more>>